WHO Essential Medicine EML section: Cytotoxic medicines
This is information only, not a prescription. Talk to a doctor or pharmacist before taking any medicine. For an overdose or poisoning, call 102.
S Caution-This preparation should be administered by individuals experienced in the administration of Vincristine Sulfate Injection. It is extremely important that the intravenous needle or catheter be properly positioned before any vincristine is injected.
Nepal brand names not included: no licence-safe source.
Vincristine Sulfate Injection is indicated in acute leukemia. Vincristine Sulfate Injection has also been shown to be useful in combination with other oncolytic agents in Hodgkin's disease, non-Hodgkin's malignant lymphomas, rhabdomyosarcoma, neuroblastoma, and Wilms' tumor.
Prior to the use of this drug, patients and/or their parents/guardian should be advised of the possibility of untoward symptoms. The most common adverse reaction is hair loss; the most troublesome adverse reactions are neuromuscular in origin.
Patients with the demyelinating form of Charcot-Marie-Tooth syndrome should not be given Vincristine Sulfate Injection. Careful attention should be given to those conditions listed under WARNINGS and PRECAUTIONS.
Pregnancy (label summary): Usage in Pregnancy See WARNINGS. Breastfeeding (label summary): Nursing Mothers It is not known whether this drug is excreted in human milk.
For a suspected overdose or poisoning, call 102 now and go to the nearest emergency hospital.
Call 102What is Vincristine used for?
Vincristine Sulfate Injection is indicated in acute leukemia. Vincristine Sulfate Injection has also been shown to be useful in combination with other oncolytic agents in Hodgkin's disease, non-Hodgkin's malignant lymphomas, rhabdomyosarcoma, neuroblastoma, and Wilms' tumor.
What are the side effects of Vincristine?
Prior to the use of this drug, patients and/or their parents/guardian should be advised of the possibility of untoward symptoms. The most common adverse reaction is hair loss; the most troublesome adverse reactions are neuromuscular in origin.
Who should not take Vincristine?
Patients with the demyelinating form of Charcot-Marie-Tooth syndrome should not be given Vincristine Sulfate Injection. Careful attention should be given to those conditions listed under WARNINGS and PRECAUTIONS.
Does Vincristine have a boxed warning?
S Caution-This preparation should be administered by individuals experienced in the administration of Vincristine Sulfate Injection. It is extremely important that the intravenous needle or catheter be properly positioned before any vincristine is injected.
Can I take Vincristine in pregnancy or while breastfeeding?
Pregnancy (label summary): Usage in Pregnancy See WARNINGS. Breastfeeding (label summary): Nursing Mothers It is not known whether this drug is excreted in human milk.
What is the dose of Vincristine?
Not provided here. Ask a doctor or pharmacist.
What is Vincristine?
Vincristine is used for: Vincristine Sulfate Injection is indicated in acute leukemia. Common side effects include: Prior to the use of this drug, patients and/or their parents/guardian should be advised of the possibility of untoward symptoms.
Sources: FDA SPL label (openFDA/DailyMed); RxNorm (NLM) · Reference · Reference · Reference
US FDA DailyMed; NLM RxNorm